Search

Your search keyword '"Ovarian high-grade serous carcinoma"' showing total 29 results

Search Constraints

Start Over You searched for: Descriptor "Ovarian high-grade serous carcinoma" Remove constraint Descriptor: "Ovarian high-grade serous carcinoma"
29 results on '"Ovarian high-grade serous carcinoma"'

Search Results

1. Serous surface papillary borderline ovarian tumors: correlation of sonographic features with clinic pathological findings.

2. Combined radiomics-clinical model to predict platinum-sensitivity in advanced high-grade serous ovarian carcinoma using multimodal MR.

3. Discordance of PD-L1 expression in primary and metastatic ovarian high-grade serous carcinoma and its correlation with CD8 + tumor-infiltrating lymphocytes and patient prognosis.

4. H&E image analysis pipeline for quantifying morphological features.

5. Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis

6. H&E image analysis pipeline for quantifying morphological features

7. Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis.

8. An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors

9. Combined radiomics-clinical model to predict platinum-sensitivity in advanced high-grade serous ovarian carcinoma using multimodal MRI.

10. Deciphering cancer genomes with GenomeSpy: a grammar-based visualization toolkit.

11. Pharmacological depletion of RNA splicing factor RBM39 by indisulam synergizes with PARP inhibitors in high-grade serous ovarian carcinoma.

12. Targeting DNA repair: the genome as a potential biomarker.

13. Pulmonary tumor thrombotic microangiopathy caused by metastatic ovarian high-grade serous carcinoma: a case report and literature review.

14. Discordance of PD-L1 expression in primary and metastatic ovarian high-grade serous carcinoma and its correlation with CD8 + tumor-infiltrating lymphocytes and patient prognosis.

15. Highly Expressed Progesterone Receptor B Isoform Increases Platinum Sensitivity and Survival of Ovarian High-Grade Serous Carcinoma

16. MicroRNA-34a/IL-6R pathway as a potential therapeutic target for ovarian high-grade serous carcinoma

17. Upfront debulking surgery versus interval debulking surgery for advanced tubo-ovarian high-grade serous carcinoma and diffuse peritoneal metastases treated with peritonectomy procedures plus HIPEC

18. Highly Expressed Progesterone Receptor B Isoform Increases Platinum Sensitivity and Survival of Ovarian High-Grade Serous Carcinoma.

19. CCNE1 Amplification and Centrosome Number Abnormality in Serous Tubal Intraepithelial Carcinoma- Further Evidence Supporting its Role as a Precursor of Ovarian High-Grade Serous Carcinoma

20. IGF-axis confers transformation and regeneration of fallopian tube fimbria epithelium upon ovulation

21. Targeting DNA repair: the genome as a potential biomarker

22. An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors

23. Molecular Clustering Based on ERα and EIG121 Predicts Survival in High-Grade Serous Carcinoma of the Ovary/Peritoneum

24. Upfront debulking surgery versus interval debulking surgery for advanced tubo-ovarian high-grade serous carcinoma and diffuse peritoneal metastases treated with peritonectomy procedures plus HIPEC.

25. MicroRNA-34a /IL-6R pathway as a potential therapeutic target for ovarian high-grade serous carcinoma.

26. IGF-axis confers transformation and regeneration of fallopian tube fimbria epithelium upon ovulation.

27. A Pathological Study Using 2014 WHO Criteria Reveals Poor Prognosis of Grade 3 Ovarian Endometrioid Carcinomas.

28. An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors.

29. Ovarian high-grade serous carcinoma with a noninvasive growth pattern simulating a serous borderline tumor.

Catalog

Books, media, physical & digital resources